Cargando…
Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis C
The purpose of this study was to determine whether serum autotaxin concentrations reflect liver stiffness in patients with chronic hepatitis C virus (HCV) treated with direct‐acting antiviral agents. Adult patients with chronic HCV were enrolled from January 2016 to August 2017. Autotaxin concentrat...
Autores principales: | Ando, Wataru, Yokomori, Hiroaki, Kaneko, Fumihiko, Kaneko, Mana, Igarashi, Koji, Suzuki, Hidekazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128230/ https://www.ncbi.nlm.nih.gov/pubmed/30202824 http://dx.doi.org/10.1002/hep4.1230 |
Ejemplares similares
-
Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2017) -
Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2018) -
Decrease in serum levels of autotaxin in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2022) -
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018) -
Urine autotaxin levels reflect the disease activity of sarcoidosis
por: Murakami, Koji, et al.
Publicado: (2022)